Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000315066-26-002771·LEXICON PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
Lexicon Pharmaceuticals Inc
COMMON STOCK · CUSIP: 528872302
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 66,743,389.66 · Class: 15.0%
- Abigail P. Johnson
Shares: 66,743,389.66 · Class: 15.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-26-002771
- Form type
- SCHEDULE 13G/A
- Filer
- LEXICON PHARMACEUTICALS, INC.
- CIK
- CIK 1062822
- Filed
- Nov 05, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership